SCHEMBL21140468

SCHEMBL21140468

Cc1nc2cc(-c3nc4cncnc4[nH]3)nnc2[nH]1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 1/20 0.31
HRH4 Q9H3N8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2141779 0.81 EGFR (0.34) HRH1HRH4
SCHEMBL18725511 0.69 NPC1 (0.36)
SCHEMBL14224800 0.67 KDM4E (0.30)
SCHEMBL6944926 0.66 ALDH1A1 (0.54)
SCHEMBL6944414 0.65 ALDH1A1 (0.40)
SCHEMBL986294 0.65 ALDH1A1 (0.37) HRH1HRH4
SCHEMBL5914424 0.64 KDM4C (0.49)
SCHEMBL7916579 0.64 CDK5 (0.42)
SCHEMBL277594 0.64 EGFR (0.33)
SCHEMBL5376580 0.63 NUDT1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3498701-B1 PRMT5 INHIBITORS AND USES THEREOF EPIZYME INC (US) 2023-02-22 EP disclosed
EP-3498701-A1 PRMT5 INHIBITORS AND USES THEREOF Epizyme Inc (US) 2019-06-19 EP disclosed